Nipecotic and iso -nipecotic amides as potent and selective somatostatin subtype-2 receptor agonists-Reference-Cited by-同舟云学术

Nipecotic and iso -nipecotic amides as potent and selective somatostatin subtype-2 receptor agonists

Published:2001-02 Issue:3 Volume:11 Page:415-417
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Zhou Changyou,Guo Liangqin,Morriello Greg,Pasternak Alex,Pan Yanping,Rohrer Susan P,Birzin Elizebeth T,Huskey Su-Er Wu,Jacks Tom,Schleim Klaus D,Cheng Kang,Schaeffer James M,Patchett Arthur A,Yang Lihu

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference10 articles.

1. Chapter 21. Non-peptide Somatostatin Receptor Ligands

2. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.

3. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase.

4. Molecular cloning and functional expression of a brain-specific somatostatin receptor.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Annotated Bibliography of Dr. Arthur A. Patchett;Journal of Medicinal Chemistry;2023-11-30

2. Computational Study of Nocardiotide-A Analogues in the Development of Technetium-99m Radiopeptides for Cancer Imaging for Targeting Somatostatin Receptor 2;Journal of Mathematical and Fundamental Sciences;2023-10-07

3. Understanding the influence of lipid bilayers and ligand molecules in determining the conformational dynamics of somatostatin receptor 2;Scientific Reports;2021-04-07

4. Toward a better understanding of the interaction between somatostatin receptor 2 and its ligands: a structural characterization study using molecular dynamics and conceptual density functional theory;Journal of Biomolecular Structure and Dynamics;2018-11-17

5. Design and synthesis of a novel series of orally active, selective somatostatin receptor 2 agonists for the treatment of type 2 diabetes;Bioorganic & Medicinal Chemistry;2017-11